Related Research Articles
Vincent Theodore DeVita Jr. is the Amy and Joseph Perella Professor of Medicine at Yale Cancer Center,and a Professor of Epidemiology and Public Health. He directed the Yale Cancer Center from 1993 to 2003. He has been president of the board of directors of the American Cancer Society (2012-2013). He is internationally recognized as a pioneer in the field of oncology for his work on combination-chemotherapy treatments.
Chandler Park is an American physician,medical journalist,and clinical researcher. In June 2021,his cancer research was published in prominent medical journals including the New England Journal of Medicine and Journal of Clinical Oncology. Park also contributes regularly as an expert physician for popular newspapers and magazines such as Newsweek,Reader's Digest,U.S. News &World Report,The Exponent-Telegram,College of St. Scholastica,and Medscape and writes medical news for Doximity.
Josep Baselga i Torres,known in Spanish as JoséBaselga,was a Spanish medical oncologist and researcher focused on the development of novel molecular targeted agents,with a special emphasis in breast cancer. Through his career he was associated with the Memorial Sloan Kettering Cancer Center,Vall d'Hebron Institute of Oncology,and the Massachusetts General Hospital in their hematology and oncology divisions. He led the development of the breast cancer treatment Herceptin,a monoclonal antibody,that targets the HER2 protein,which is impacted in aggressive breast cancers.
Harry F. Bisel,M.D. (1918–1994) was an American oncologist. With Fred Ansfield,Herman Freckman,Arnoldus Goudsmit,Robert Talley,William Wilson,and Jane Wright,was one of the founding members of the American Society of Clinical Oncology (ASCO). This group of pioneering doctors,through the formation of ASCO,is largely credited with the development of modern American clinical oncology. In 1964,Bisel was elected the first president of ASCO. He was active in the American Cancer Society and was a consultant to the National Cancer Institute. Bisel was a founding member of the American Society of Preventive Oncology as well as the American Association for Cancer Education.
Olufunmilayo I. Olopade born in the year 1957,is a Nigerian hematology oncologist,Associate Dean for Global Health and Walter L. Palmer,Distinguished Service Professor in Medicine and Human Genetics at the University of Chicago. She also serves as director of the University of Chicago Hospital's Cancer Risk Clinic.
Jonathan S. Berek, MD MMS is the Laurie Kraus Lacob Professor at the Stanford University School of Medicine,Director of the Stanford Women's Cancer Center,and Senior Advisor,Stanford Cancer Institute. He is a recent past Fellow in the Stanford Distinguished Careers Institute.
Naoto T. Ueno is Director of the University of Hawaiʻi (Mānoa) Cancer Center,one of the 74 NCI National Cancer Centers. He was formerly Professor of Medicine at The University of Texas MD Anderson Cancer Center,and was also a visiting professor with the Keio University. Ueno's research is in the area of inflammatory breast cancer and the molecular mechanism of metastasis and tumorigenicity.
Eric P. Winer is a medical oncologist and clinical researcher specializing in breast cancer. He is director of Yale Cancer Center and president and physician-in-chief of Smilow Cancer Hospital Yale New Haven Health System,effective February 1,2022. He also is Deputy Dean for Cancer Research at Yale School of Medicine. From 1997 to 2021,he was the Chief of the Breast Oncology Program at Dana–Farber Cancer Institute in Boston,Massachusetts. Beginning in 2013,he held a range of institutional roles at Dana-Farber,including Chief of Clinical Development,the Thompson Chair in Breast Cancer Research and Director of the Dana-Farber/Harvard SPORE in Breast Cancer. He also served as a Professor of Medicine at Harvard Medical School. He was president of the American Society of Clinical Oncology (ASCO) 2022-2023 and became Chair of the Board in mid-June 2023. His career has been focused on breast cancer treatment and research.
Sandra M. Swain is an American oncologist,breast cancer specialist and clinical translational researcher. She is currently a professor of Medicine at the Georgetown University School of Medicine and the Associate Dean for Research Development at Georgetown University Medical Center (GUMC) and MedStar Health as well as an adjunct professor of Medicine at the F. Edward Hébert School of Medicine of the Uniformed Services University of Health Sciences. She is also a past President of the American Society of Clinical Oncology (ASCO),serving from 2012 through 2013.
William G. Kaelin Jr. is an American Nobel laureate physician-scientist. He is a professor of medicine at Harvard University and the Dana–Farber Cancer Institute. His laboratory studies tumor suppressor proteins. In 2016,Kaelin received the Albert Lasker Award for Basic Medical Research and the AACR Princess Takamatsu Award. He also won the Nobel Prize in Physiology or Medicine in 2019 along with Peter J. Ratcliffe and Gregg L. Semenza.
Steven T. Rosen is the executive vice president and director emeritus of City of Hope's Beckman Research Institute and cancer center. He was previously the provost and chief scientific officer of City of Hope National Medical Center in Duarte,California. In addition to previously directing City of Hope's Comprehensive Cancer Center,he also led the Beckman Research Institute at City of Hope and the Irell &Manella Graduate School of Biological Sciences. Previously (1989-2014),Rosen was the director of the Robert H. Lurie Comprehensive Cancer Center at Northwestern University,which was awarded comprehensive cancer center status by the National Cancer Institute (NCI) in 1997.
Judy Ellen Garber is the director of the Center for Cancer Genetics and Prevention at the Dana–Farber Cancer Institute and a professor of medicine at Harvard Medical School. Garber previously served as president of the American Association for Cancer Research.
Ann Hart Partridge is an American medical oncologist. She is the founder and director of the Young and Strong Program for Young Women with Breast Cancer at the Susan F. Smith Center for Women's Cancers at the Dana–Farber Cancer Institute.
Everett E. Vokes is an American oncologist. He is the John E. Ultmann Professor,chair of the Department of Medicine,and physician-in-chief at the University of Chicago Medical Center. In this role,he pioneered the combination radiation and chemotherapy as first-line treatment for head and neck cancer.
Sonali Mehta Smith is an American oncologist. She is the Elwood V. Jensen Professor and Chief of the Hematology/Oncology Section at the University of Chicago.
Lori Jo Pierce is an American radiation oncologist and 57th President of the American Society of Clinical Oncology. She is a Full Professor and Vice Provost for Academic and Faculty Affairs at the University of Michigan. Her research focuses on the use of radiotherapy in the multi-modality treatment of breast cancer,with emphasis on intensity modulated radiotherapy in node positive breast cancer,the use of radiosensitizing agents,and the outcomes of women treated with radiation for breast cancer who are carriers of a BRCA1/2 breast cancer susceptibility gene.
Maura Lianne Gillison is an American medical oncologist and molecular epidemiologist. She is credited as the first investigator to establish a connection between HPV and oral cancer.
Monica Bertagnolli is an American surgical oncologist and the 17th director of the National Institutes of Health. She previously served as the 16th director of the National Cancer Institute (NCI). Prior to her governmental positions,she worked at Brigham and Women's Hospital and Dana–Farber Cancer Institute and was the Richard E. Wilson Professor of Surgery at Harvard Medical School.
Nancy Lin is an American oncologist who works at the Dana-Farber Cancer Institute and is an Associate Professor of Medicine at Harvard Medical School. Her research considers new diagnostic strategies and treatment pathways for HER2 positive breast cancer.
Ophira Michal Ginsburg is a Canadian oncologist.
References
- ↑ "Stephanie Lynn (Schutt) Graff, MD". doximity.com. Doximity . Retrieved February 16, 2021.
- ↑ "Stephanie L. Graff, MD". Lifespan Institute. Retrieved 8 May 2023.
- ↑ "Graff, Stephanie". Researchers@Brown. Brown University. Retrieved 8 May 2023.
- ↑ "I Live to Conquer Cancer: Dr. Stephanie Graff". connection.asco.org. ASCO. September 23, 2019. Retrieved February 16, 2019.
- 1 2 3 "Real Wives of Leawood: Stephanie Graff". mymidwestphysician.com. November 11, 2013. Retrieved February 16, 2021.
- 1 2 3 "Dr. Susan Love Foundation for Breast Cancer Research Welcomes New Medical Advisor Stephanie Graff, MD" (PDF). drsusanloveresearch.org. October 6, 2020. Retrieved February 16, 2021.
- ↑ "Stephanie Graff, MD, FACP, Sarah Cannon Research Institute HCA Midwest, ASCO Selectee". hcamidwest.com. July 30, 2019. Retrieved February 16, 2021.
- ↑ "Dr. Ashley Love Sumrall, Dr. Stephanie Graff Win 2019 APEX Awards for ASCO Connection Blog Posts". connection.asco.org. ASCO. August 6, 2019. Retrieved February 16, 2021.
- ↑ "Stephanie Graff named director of breast oncology at Lifespan Cancer Institute". 30 July 2021.
- ↑ "Could Rhode Island become the next cancer research hub? - the Boston Globe". The Boston Globe .
- ↑ "Stephanie Graff : Publications". Researchers@Brown. Brown University. Retrieved 8 May 2023.
- ↑ "Editorial Board". Cancer Medicine. doi:10.1002/(ISSN)2045-7634 . Retrieved 8 May 2023.
- ↑ "Editorial Board : American Journal of Clinical Oncology".
- ↑ "Honor National Women Physicians Day With Self-Care". connection.asco.org. February 1, 2019. Retrieved February 16, 2021.